Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-01

FDA Approved: NEBIVOLOL — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Nebivolol under an Original Application (ANDA) from Novadoz Pharmaceuticals LLC, resulting in a generic product for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL)